Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of Tetraxim Versus Local DTP + IPV
This study has been completed.
Study NCT00319852   Information provided by Sanofi

First Received on April 28, 2006.   Last Updated on April 13, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pertussis
Diphtheria
Poliomyelitis
Tetanus
Additional conditions recognized in this trial
Tetany
Whooping Cough
More general conditions related to this trial
Actinomycetales Infections
Bacterial Infections
Bordetella Infections
Calcium Metabolism Disorders
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Clostridium Infections
Corynebacterium Infections
Enterovirus Infections
Gram-Negative Bacterial Infections
Gram-Positive Bacterial Infections
Hypocalcemia
Infection
Metabolic Diseases
Myelitis
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Neuromuscular Manifestations
Picornaviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Signs and Symptoms
Spinal Cord Diseases
Virus Diseases
Interventions listed in this trial
DTaP-IPV combined vaccine
DTaP vaccine
Sponsors listed in this trial
Sanofi


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services